BioAtla, Inc. (BCAB) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Join SI Premium – FREE
BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Goldman Sachs Upgrades RENK Group AG (R3NK:GR) to Buy
- JPMorgan Starts Sigma Lithium Corp (SGML:CN) (SGML) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
